Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant MARV GP1/Envelope glycoprotein 1 Protein, C-Fc

Catalog #:   EVV24305 Specific References (12) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: Mammalian cells
Accession: Q1PDC7
Protein length: Val33-Thr425
Overview

Catalog No.

EVV24305

Expression system

Mammalian cells

Species

Lake Victoria marburgvirus (strain Ravn-87) (MARV) (Marburg virus (strain Kenya/Ravn/1987))

Protein length

Val33-Thr425

Predicted molecular weight

71.21 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q1PDC7

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Envelope glycoprotein, GP1,2, GP, Virion spike glycoprotein, GP1

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant MARV GP1/Envelope glycoprotein 1 protein
References

Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine design., PMID:39285186

Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease., PMID:30285648

Toremifene interacts with and destabilizes the Ebola virus glycoprotein., PMID:27362232

Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein., PMID:26468532

Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry., PMID:25741008

Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein., PMID:25514232

Crystal structure of the Marburg virus GP2 core domain in its postfusion conformation., PMID:22935026

Filovirus entry: a novelty in the viral fusion world., PMID:22470835

Marburg virus glycoprotein GP2: pH-dependent stability of the ectodomain α-helical bundle., PMID:22369502

Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus., PMID:21253575

Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events., PMID:17475648

Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs., PMID:12686428

Datasheet
$ 480
Product specifications
100 μg 480 1 mg 2880

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant MARV GP1/Envelope glycoprotein 1 Protein, C-Fc [EVV24305]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only